EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer

Divya Shah, Kristen Young

Cureus · 03.12.2023

DOI: 10.7759/cureus.49867 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 03.12.2023. Verfasst von Divya Shah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

immune therapy-mediated myocarditismyositis-mg overlapnew drug reactionpembrolizumab side effectpembrolizumab-induced myasthenia gravis

Autor:innen und Institutionen

  • Internal Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, USA.
  • Rheumatology, University of Arizona College of Medicine - Phoenix, Phoenix, USA.

Zitieren

APA

Shah, D., & Young, K. (2023). Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer. Cureus. https://doi.org/10.7759/cureus.49867

Vancouver

Shah D, Young K. Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer. Cureus. 2023. doi:10.7759/cureus.49867

BibTeX
@article{Shah2023,
  author = {Shah, Divya and Young, Kristen},
  title = {Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer},
  journal = {Cureus},
  year = {2023},
  doi = {10.7759/cureus.49867}
}
Kostenlos starten →